Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 20;34(9):987-1011.
doi: 10.1200/JCO.2015.65.8427. Epub 2016 Feb 4.

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Affiliations

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Don S Dizon et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST Disclosures provided by the authors are available with this article at www.jco.org.

Figures

Fig 1
Fig 1
Sustained robust federal funding critical to cancer progress.
Fig 2
Fig 2
Immune checkpoint inhibitors: releasing the brakes on the immune system. Immune checkpoints function like brakes on the immune system, controlling the strength and duration of immune responses. MHC, major histocompatibility complex; PD-L1, programmed death-ligand 1; TCR, T-cell receptor.

References

    1. American Cancer Society: Cancer Facts & Figures 2015. http://www.cancer.org/acs/groups/content/@editorial/documents/document/a....
    1. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921. - PubMed
    1. Henley SJ, Singh SD, King J, et al. Centers for Disease Control and Prevention (CDC): Invasive cancer incidence and survival: United States, 2011. MMWR Morb Mortal Wkly Rep. 2015;64:237–242. - PMC - PubMed
    1. American Cancer Society: Cancer Treatment & Survivorship Facts & Figures (2014-2015) www.cancer.org/acs/groups/content/@research/documents/document/acspc-042....
    1. Robert C, Schachter J, Long GV, et al. KEYNOTE-006 investigators: Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med. 2015;372:2521–2532. - PubMed

Publication types